Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Aberrant Crypt Foci 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 25Blood Specimen Collection 20Radiotherapy 19Surveys and Questionnaires 18Exercise 17Early Intervention, Educational 17Methods 16Standard of Care 15Cyclophosphamide 15Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 14Biopsy 13Acupuncture Therapy 12Interviews as Topic 11Educational Status 11Cisplatin 11Filgrastim 10Radiofrequency Ablation 9Magnetic Resonance Imaging 9Fluorodeoxyglucose F18 9fludarabine phosphate 8Radiation 8Practice Guidelines as Topic 8Gemcitabine 8X-Rays 7Sorafenib 7Granulocyte Colony-Stimulating Factor 7Colonoscopy 7Capecitabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Terminated × Sulindac × Clear all
NCT00003365 2011-01-27

Sulindac and Plant Compounds in Preventing Colon Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00176618 2009-12-11

The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon

Rutgers, The State University of New Jersey

Phase NA Terminated
60 enrolled

Aberrant Crypt Foci

Data powered by HemOnc (CC BY 4.0) Colophon âš¡